GlaxoSmithKline (GSK) is a science-led, global healthcare company that researches and develops innovative products. GSK currently employ over 100,000 people globally and has offices in more than 115 countries. At GSK, our mission is to improve the quality of human life by enabling people to do more, feel better, live longer. We need a talented, motivated and resilient workforce if we are to deliver against our strategy and tackle global health challenges effectively. To achieve this, we aim to create a working environment where employees feel valued, respected, empowered and inspired. R&D innovation underpins all of our businesses. We partner with more than 1,500 other companies and academic organizations around the world, enabling us to increase our understanding of new areas of science and to share the risk of development. We have a deep portfolio of innovation focused across six core areas of scientific research and development: HIV and infectious diseases, oncology, immuno-inflammation, vaccines, respiratory and rare diseases. Personally, I have more than 20 years of experience in leading R&D and commercial analytical development projects and have demonstrated expertise in QbD approaches to analytical lifecycle management, new platform technology development, analytical method development and validation, and regulatory strategy. My current role is Director of Biopharmaceutical Analytical Project Leadership which has afforded me the opportunity to provide scientific and operational leadership to CMC project teams for development and delivery of stage appropriate analytical strategies for Biopharmaceuticals.